Victoria Harle
Wellcome Sanger Institute(GB)Shri Vile Parle Kelavani Mandal(IN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Ubiquitin and proteasome pathways, CRISPR and Genetic Engineering, Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics
Most-Cited Works
- → Combinatorial CRISPR screen identifies fitness effects of gene paralogues(2021)133 cited
- → Deubiquitinating Enzyme Usp12 Is a Novel Co-activator of the Androgen Receptor(2013)101 cited
- → Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway(2014)58 cited
- → Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer(2019)45 cited
- → Genetic determinants of micronucleus formation in vivo(2024)44 cited
- → The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma(2021)39 cited
- → Sprouty2 loss‐induced IL 6 drives castration‐resistant prostate cancer through scavenger receptor B1(2018)32 cited
- → In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer(2020)19 cited
- → CRISPR activation screen in mice identifies novel membrane proteins enhancing pulmonary metastatic colonisation(2021)18 cited
- → Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer(2015)15 cited